|
Department
|
Study Title
|
|
Anesthesiology
|
A Randomized, Double-Blind Comparison of Oral Aprepitant Alone vs Oral Aprepitant and Transdermal Scopolamine for Preventing Postoperative Nausea and Vomiting
|
|
Anesthesiology
|
A multi-center, randomized, parallel group, comparative, active controlled, safety assessor blinded trial in Adult subjects comparing rocuronium plus sugammadex versus succinylcholine alone in subjects undergoling short surgical procedures in out-patient surgicenters assessor blinded trial in adult subjects comparing rocuronium plus sugammadex versus succinylcholine alone in subjects undergoing short surgical procedures.
|
|
Cardiovascular Medicine & Surgery
|
Gore Embolic Filter in Carotid Stenting for High Risk Surgical Subjects
|
|
Cardiovascular Medicine & Surgery
|
The HeartMate II LVAS Pivotal Study
|
|
Cardiovascular Medicine & Surgery
|
Carotid Stenting For High Surgical-Risk Patients; Evaluating Outcomes Through The Collection Of Clinical Evidence
|
|
Cardiovascular Medicine & Surgery
|
Stenting and Angioplasty with Protection in Patients at High Risk for Endarterectomy
|
|
Cardiovascular Medicine & Surgery
|
Prospective AneurYsm Trial: High AnGle AORfix™ BifurcAted Stent Graft.
|
|
Cardiovascular Medicine & Surgery
|
XIENCE V Everolimus Eluting Coronary Stent System USA Post-Approval Study
|
|
Emergency Medicine
|
Phase 2 SBIR Grant N00014-05-C-0516 from the Department of the Navy for support of a project
|
|
Medicine - CME
|
The Effect of Sulodexide in Overt Type 2 Diabetiic Nephropathy
|
|
Medicine - Endocrinology
|
A Multi Center, Double Blind Palacebo-Controlled, Parallel-Group Randomized, Phase 2 Trial to evaluate the glycemic efficacy, renal safety, pharmacokinetics and pharmacodynamics of Dapagliflozin in subjects with Type 2 Diabetes Mellitus and Moderate Renal Impairment who have inadquate Glycemic Control
|
|
Medicine - EPS Card
|
SMARTDELAY determined AV Optimization: A Comparison to Other AV Delay Methods Used in Cardiac Resynchronization Therapy (SMART-AV)
|
|
Medicine - EPS Card
|
Ovatio CRT and Situs OTW LV Lead Post Approval Study (Ovatio CRT PAS)
|
|
Medicine - EPS Card
|
A Multicenter, Randomized, Double-blind, Assessor-blind, Non-inferiority Study Comparing the Efficacy and Safety of Once-Weekly Subcutaneous Biotinylated Idraparinux (SSR126517E) with Oral Adjusted Dose Warfarin in the Preventive of Stroke and Systemicthrombioembolic Events in Patient with Atrial Fibrillation.
|
|
Medicine - EPS Card
|
Attain StarFix® Model 4195 LV Lead Extraction Study
|
|
Medicine - EPS Card
|
Registry of AT/AF Episodes in the CRM Device Population: RATE Registry with RATE CRT Sub-registry
|
|
Medicine - EPS Card
|
St. Jude Medical Product Longevity and Performance (SCORE) Registry
|
|
Medicine - EPS Card
|
BLOCK HF (Biventricular versus Right Ventricular Pacing in Heart Failure Patients with Atrioventricular Block)
|
|
Medicine - EPS Card
|
A Phase III Clinical Trial Comparing Rivaroxaban to Warfarin in Patients with Non-Valvular Atrial Fibrillation
|
|
Medicine - GIM
|
A Phase 3, Randomized, Open Label Study of Neratinib Versus Lapatinib Plus Capecitabine for the Treatment of ErbB-2-Positive Locally Advanced or Metastatic Breast Cancer
|
|
Medicine - Heart Failure
|
CSPP100A2368 A Multicenter, Randomized, Double-Blind, Parallel Group, Placebo-Controlled Study to Evaluate the 6 Months Efficacy and Safety of Aliskiren Therapy on Top of Standard Therapy, on Morbidity and Mortality When Initiated Early After Hospitalization for Acute Decompensated Heart Failure
|
|
Medicine - Heart Failure
|
"A Phase II, Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of PROCHYMAL® (Ex Vivo Cultured Adult Human Mesenchymal Stem Cells) Intravenous Infusion Following Acute Myocardial Infarction
|
|
Medicine - Heart Failure
|
A Multicenter, Randomized, Double-blind, Placebo-Controlled, Parallel-Group, Multiple-Dose Study to Evaluate the Effects of RLY5016 in Congestive Heart Failure Patients
|
|
Medicine - Heart Failure
|
A Phase 3 Randomized, Double-blind, Parallel-group, Multi-center Study of the Safety and efficacy of Apixaban for Prophylaxis of venous Thromboembolism in Acutely III medical subjects during and following hospitalization
|
|
Medicine - Heart Failure
|
Registry to Improve the Use of Evidence-Based Heart Failure Therapies in the Outpatient Setting (IMPROVE HF)
|
|
Medicine - Heart Failure
|
Medtronic Chronicle ICD Implantable Cardioverter Defibrillator Clinical Investigational Plan Metronic desires the investigator to perform a study of the medrronic Chronicle implantable cardioverter Defibrillator(Dive and the Medtronic senor lead (lead) us
|
|
Medicine - Heart Failure
|
A Facilitated Access Program to Provide Everolimus for Maintenance Patients Completing Therapy in RAD trials in Solid Organ Transplantation.
|
|
Medicine - Heart Failure
|
Double-Blind, Placebo-Controlled, Multicenter Acute Study of Clinical Effectiveness of Nesiritide in Subjects With Decompensated Heart Failure ASCEND-HF
|
|
Medicine - Heart Failure
|
Who Benefits from Cardiac Resynhronization Therapy
|
|
Medicine - Heart Failure
|
A Randomized Open-Label Study to Compare the Safety and Efficacy of Conversion from a Calcineurin Inhibitor to Sirolimus Versus Continued Use of a Calcineurin Inhibitor in Cardiac Transplant Recipients with Mild to Moderate Renal Insufficency
|
|
Medicine - Heart Failure
|
Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction (REVERSE)
|
|
Medicine - Heart Failure
|
Long Term,Open Label Follow-Up Treatment of Patients with Atrial Fibrillation Who Have Been Previously Treated with BIBR 1048 in the PETRO Trial (Trial 1160.20)
|
|
Medicine - Heart Failure
|
A 24-month, multi-center, randomized, open-label non-inferiority study of efficacy and safety comparing two exposures of concentration-controlled Certican with reduced Neoral versus 3.0 g MMF with standard dose Neoral in de novo heart transplant recipients
|
|
Medicine - Infectious Disease
|
Prospective Study of Ophthalmologic Funciton in Patients Receiving Linezolid for Two Months or Greater
|
|
Medicine - Infectious Disease
|
A Phase II Study Testing the Activity and Safety of AGS 004 as an Immunotherapeutic in Successfully ART-Treated Subjects Infected with HIV-1 in Combination with ART Followed by ART Interruption
|
|
Medicine - Infectious Disease
|
A Mult-National, Multi-Center, Double-Blind, Randomized, Parallel Group Study to Compare the Safety and Efficacy of 200 mg PAR-101 Taken q12h with 125 mg Vancomycin Taken q6h for Ten Days in Subjects with Clostridium Difficile-Associated Diarrhea
|
|
Medicine - Infectious Disease
|
A Multicenter, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Safety and Antiretroviral Activity of MK-0518 in Combination With an Optimized Background Therapy (OBT), Versus Optimized Background Therapy Alone, in HIV-Infected Patients With Documented Resistance to at Least 1 Drug in Each of the 3 Classes of Licensed Oral Antiretroviral Therapies
|
|
Medicine - Infectious Disease
|
A Randomized, Observer-Blind, Active-Controlled Phase III Study to Demonstrate the Superior Efficacy of GSK Biologicals’ Adjuvanted Influenza Candidate Vaccine [GSK2186877A] Administered Intramuscularly in Elderly Aged 65 Years or Above as Compared to Flu
|
|
Medicine - Neoplastics
|
A Phase III, Multi-center, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of the Efficacy and safety of Lenalidomide (Revlimid) as Maintenance Therapy for Patients with B-Cell Chronic Lymphocytic Leukemia Following second-line Therapy ( The Continuum Trial)
|
|
Medicine - Neoplastics
|
A Study of Pazopanib versus Sunitinib in the Treatment of Subjects with Locally Advanced and/or Metastatic Renal Cell Carcinoma
|
|
Medicine - Nephrology
|
A Randomized, Placebo Controlled, Double-Blind Comparative Study Evaluating the Effect of Ramipril on Urinary Protein Excretion in Maintenance Renal Transplant Patients Converted to Sirolimus
|
|
Medicine - Nuclear Cardiology
|
A Phase 3b, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Effect of Caffeine Intake on Single Photon Emission Computed Tomography (SPECT) Myocardial Perfusion Imaging (MPI) in Subjects Administered Regadenoson
|
|
Medicine - Nuclear Cardiology
|
A Safety and Efficacy Trial Evaluating the Use of Apixaban in the Treatment of Symptomatic Deep Vein Thrombosis and Pulmonary Embolism Samples for Pfizer’s Exploratory Research Biobank
|
|
Medicine - Nuclear Cardiology
|
A Safety And Efficacy Trial Evaluating The Use Of Apixaban For The Extended Treatment Of Deep Vein Thrombosis And Pulmonary Embolism
|
|
Medicine - Nuclear Cardiology
|
A Double-Blind, Placebo-Controlled, Randomized, Multi-Center, Dose-Finding Study of SLV320, a Selective A1 Adenosine Receptor Antagonist, to Evaluate the Effect on Renal Function and Safety in Subjects Hospitalized with Acute Decompensated Heart Failure and Renal Dysfunction
|
|
Medicine - Nuclear Cardiology
|
A Double-blind, Randomized, Placebo-controlled, Multicenter Study to Assess the Efficacy and Safety of Darbepoetin Alfa Treatment on Mortality and Morbidity in Heart Failure (HF) Subjects with Symptomatic Left Ventricular Systolic Dysfunction and Anemia
|
|
Neurology
|
Investigational Drug/Device for use in patients with Amyotrophic Lateral Sclerosis
|
|
Neurology
|
An International, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study To Evaluate The Efficacy And Safety Of Two Year Treatment With Teriflunomide 7 Mg Once Daily And 14 Mg Once Daily Versus Placebo In Patients With A First Clinical Episode Suggestive Of Multiple Sclerosis
|
|
Neurology
|
An International, Multi-Center, Double-Blind, Parallel-Group, Placebo-Controlled Study To Evaluate The Efficacy And Safety Of Teriflunomide 7mg Once Daily And 14mg Once Daily Versus Placebo In Patients With Relapsing Multiple Sclerosis Using Interferon-Beta 1a (Rebif®) As An Open-Label Rater-Blind Calibrator
|
|
Neurology
|
Case-Crossover Study of PDE5 Inhibitor Exposure as a Potential "Trigger Factor" for Acute NAION
|
|
Neurology
|
A Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Assess the Safety and Efficacy and to determine the Pharmacokinetics fo two doses of AVP-923 (Dextromethorphan/Quinidine) in the treatment of Pseudobulbar Affect (PBA) in Poatients with
|
|
Neurology
|
TYGRIS: TYSABRI Global Observational; program in safety
|
|
Neurology
|
A 52-week, multi-center, randomized, double-blind,placebo-controlled, parallel group study in patients with mild Alzheimer's disease (AD) to investigate the safety and tolerability of repeated subcutaneous injections of CAD 106
|
|
Obsterics / Gynecology
|
A Pivotal Study of Doppler Guided Uterine Artery Occlusion as Treatment for the Reduction of Fibroid Associated Bleeding as Treatment for the Reduction of Fibroid Associated Bleeding
|
|
Obsterics / Gynecology
|
Comparison of SureCALL™ EMG Labor Monitor and Tocodynamometer to Intrauterine Pressure Catheter Measurements in Pregnant Women
|
|
Obsterics / Gynecology
|
Non-Invasive and Invasive Technology
|
|
Orthopedic Surgery
|
Post-Approval Study Protocol Stelkast Surpass
|
|
Orthopedic Surgery
|
A Prospective Study on Revision Knee Arthroplasty Using Stelkast Revision Knee Prosthesis (Stelkast TM)
|
|
Pediatrics
|
Long Term Administration of Inhaled Mannitol In Cystic Fibrosis – A Safety and Efficacy Study Safety and Efficacy Study
|
|
Pediatrics
|
Mepilex Ag / An Open, Parallel, Randomized, Comparative, Multi-Centre Investigation In US Evaluating The Cost-Effectiveness, Efficacy, Safety And Tolerance Of Mepilex® Ag Versus Silvadene® In The Treatment Of Partial Thickness Burns.
|
|
Pediatrics
|
A Randomized Comparison Study of a Flexible Hydrogel Nanoparticle Wound Dressing with Silver (AltrazealTM Silver) Versus a Sodium Carboxymethyl-cellulose Dressing with Silver (AquacelÒ Ag) for Partial Thickness Skin Donor Sites
|
|
Pediatrics
|
A Phase 4, Open-Label, Single-Group Safety and Immunogenicity Study of RECOTHROM® (rThrombin) in Pediatric Subjects Undergoing Synchronous Burn Wound Excision and Skin Grafting
|
|
Pediatrics
|
SINCERE: Safety in Idiopathic Arthritis: NSAIDS and Celebrex Evaluation Registry: A Prospective Observational Registry of Patients with Juvenile Idiopathic Arthritis (JIA) Treated with NSAIDS
|
|
Pediatrics
|
Exjade CICL670AUS32 A single-arm, open-label study of the Palatability and Tolerability of Exjade Taken with Meals, with Different Liquids or Crushed and Added to Food
|
|
Pediatrics
|
The Risk of Thrombotic Events in Neonates Following the Use of Recombinant Factor VIIa
|
|
Pediatrics
|
The EPIC Observational Study
|
|
Pediatrics
|
A Double-Blind, Multicenter, Multinational, Randomized, Placebo-Controlled Trial Evaluating Aztreonam Lysine for Inhalation in Patients with Cystic Fibrosis, Mild Lung Disease and P. aeruginosa (AIR-CF4 Placebo-Controlled Trial Evaluating Aztreonam Lysine for Inhalation in Patients with Cystic Fibrosis, Mild Lung Disease, and P. aeruginosa (AIR-CF4)
|
|
Pediatrics
|
An Open-Label, Non-comparative, Multi-centre Study to Assess The Efficacy and Safetyof Bicalutamide when used in Combination with Anastrozole for the Treatment of Gonadotropin-Independent Precocious Puberty in Boys with Testotozicosis
|
|
Pediatrics
|
Participation in Norditropin National Registry - Novo Nordisk National Registry
|
|
Pediatrics
|
Pfizer International Growth Study_KIGS" Protocol: TRN 87-052-45[CCID:A6281276 An International Non-Interventional Safety Multi-Center and Consist of Data Collection on Paitents Receiving Treatment with Pfizer Product Genotropin as Part of their Standard
|
|
Pediatrics
|
Prospective Advate Immune Tolerance Induction Registry
|
|
Pediatrics
|
An Open-Label Study to Evaluate Prophylaxis Treatment, and to Characterize the Efficacy, Safety and Pharmacokinetics, of B-Domain Deleted Recombinant Factor VIII Albumin Free (ReFacto AF) in Children with Hemophilia A
|
|
Pediatrics
|
A Phase III. Randomized, Open-Label Study Comparing the Safety and Efficacy of switching stavudine or Zidovudine to Tenofovir Disoproxil Fumarate versus Continuing Stavudine or Zidovudine in Virologically Suppressed HIV Infected Children taking highly act
|
|
Pediatrics
|
Prospective Evaluation of the Effects of Topical Therapy with Sulfamylon for 5% Topical Solution on Autograft Healing in Subjects with Thermal Injuries Requiring Meshed Autografts: A Comparison to a Historical Control Group Sulfamylon® For 5% Topical Solution on Autograft Healingin Subjects with Thermal Injuries Requiring Meshed Autografts: A Comparison to a Historical Control Group
|
|
Psychiatry
|
Protocol No. 64,185-01-3W- Long-Term Clinical Follow-up of Children Enrolled in Stannsoporfin clinical Trial
|
|
Psychiatry
|
Risperidone in the Treatment of Children and Adolescents with Autistic Disorder: A Double-Blind, Placebo-Controlled Study of Efficacy and Safety Followed by an Open-Label Extension Study
|
|
Pulmonary
|
A Double-Blind, Multicenter, Multinational, Randomized,Placebo-Controlled Trial Evaluating Aztreonam Lysine for Inhalation in Patients with Cystic Fibrosis, Mild Lung Disease and P. Aeruginosa (AIR-CF4) Placebo-Controlled Trial Evaluating Aztreonam Lysine for Inhalation in Patients with Cystic Fibrosis, Mild Lung Disease, and P. aeruginosa (AIR-CF4)
|
|
Pulmonary
|
A Phase 2, Double-Blind, Multicenter, Randomized, Placebo-Controlled Trial Evaluating Fosfomycin/Tobramycin for Inhalation in Patients with Cystic Fibrosis and Pseudomonas aeruginosa
|
|
Pulmonary
|
A Phase 2 Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety Tolerability and Efficacy of Three Dosage Regimens of MP-376 Solution for Inhalation Given for 28 Days to Stable Cystic Fibrois Patients
|
|
Pulmonary
|
Expanded Access Program for Aztreonam Lysine for Inhalation in Patients with Cystic Fibrosis and Pseudomonas aeruginosa Airway Infection who have limited treatment options and are at risk for Disease Progression
|
|
Pulmonary
|
Linezolid in the Treatment of Subjects with Nosocomial Pneumonia proven to be due to Methicillin-Resistant Staphylococcus Aureus
|
|
Surgery
|
One Year exploratory study to evaluate the safety fof partial replacement of CNI with chronic administration of Simulect® in de novo normal-risk kidney transplant recipients treated with MPA
|
|
Surgery
|
A Phase 3, Open-label, Multicenter, Prospective, Randomized Study of the Efficacy and Safety of Conversion from Prograf® Capsules Twice Daily to LCP Tacro™ Tablets Once Daily for the Prevention of Acute Allograft Rejection in Stable Kidney Transplant Patients
|
|
Surgery
|
A Phase 2, Multicenter, Open Label, Active Comparator-Controlled, Extension Trial To Evaluate The Long Term Safety And Efficacy Of CP690,550 In Renal Allograft Recipients
|
|
Surgery
|
A 24-Month, Multi-Center, Randomized, Open Label Non-Inferiority Study Of Efficacy And Safety Comparing Concentration-Controlled Certican In Two Doses (1.5 Ad 3.0 Mg/Day Starting Doses) With Reduced Neoral Versus 1.44 Mg Myfortic With Standard Dose Neoral In De Novo Renal Transplant Recipientsation-Controlled
|
|
Surgery
|
A Phase 2, Randomized, Multicenter, Active Comparator-Controlled Trial to Evaluate the Safety and Efficacy of Codministration of CP-690,550 and Mycophenolate Mycophenolate Sodium in De Novo Kidney Allograft Recipients
|
|
Surgery
|
Maintenance with Sirolimus based Immunosuppression in HIV Positive Renal
|
|
Surgery
|
A Case Controlled Database Analysis To Evaluate If Simulect® (Basiliximab) Enables Two Day Steroid Withdrawalin Kidney Re-Transplantation
|
|
Surgery
|
A Phase 3, Active (Warfarin) Controlled, Randomized, Double-Blind, Parallel Arm Study to Evaluate Efficacy and Safety of Apixaban in Preventing Stroke and Systemic Embolism in Subjects with Nonvalvular Atrial Fibrillation
|
|
Surgery
|
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression
|
|
Surgery
|
Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immuno- suppression Trial - Extended criteria donors
|
|
Surgery
|
A phase IV, non-interventional, multi-center, open-label, prospective, observational study of the safty, effectiveness, tolerablity, and compliance of immunosuppressive regimens using mycophendic acid to treat de novo renal transplant patients in a routine
|